EML
Home
Recent Updates
Favourites
Search
Directory
Guidelines
Medicines
Tools
About
Feedback
Disclaimer
Directory
Guidelines
Search
Medicines
Tools
Antineoplastic and Immunomodulating Agents
Temozolomide
ATC Code
Indication
NEMLC Recommendation
Review Indicators
Date Ratified
ATC CODE
L01AX03
INDICATION
Glioblastoma multiforme.
NEMLC RECOMMENDATION
Not Approved
REVIEW INDICATORS
Prospective
RCTs
demonstrating a significant increase in effect size.
Significant price reduction.
DATE RATIFIED
25 July 2013